undefined undefined
NaN.000
NaN.00%
DermTech (NASDAQ:DMTK) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.57) by 1.75 percent. The company reported quarterly sales of $3.85 million which missed the
05-15 04:30
DermTech (NASDAQ:DMTK) underwent analysis by 4 analysts in the last quarter, re...
04-20 01:01
BTIG analyst Sung Ji Nam downgrades DermTech (NASDAQ:DMTK) from Buy to Neutral.
04-19 18:35
DermTech (NASDAQ:DMTK) said its board has engaged TD Cowen to explore strategic alternatives for the company and that it plans to cut approximately 56% of its workforce to conserve cash. The genomics ...
04-19 04:54
Unity Software(U.US) reported fourth-quarter financial results after the market...
04-19 04:37
The Company anticipates incurring a one-time restructuring charge of approximately $1.6 million in the second quarter of 2024 in connection with these restructuring actions. The company believes it
04-19 04:20
BTIG analyst Mark Massaro maintains DermTech (NASDAQ:DMTK) with a Buy and lowers the price target from $4 to $2.
03-08 00:42
DermTech (NASDAQ:DMTK) reported its Q4 earnings results on Thursday, February 2...
03-01 05:05
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
02-29 18:15